ch.oddb.org
 
Medikamente | Services | Zulassungsi.
Home - Fachinformation zu Orladeyo 150 mg - Änderungen - 13.03.2025
1 Änderungen an Fachinfo Orladeyo 150 mg
  • -Gesuchs ID Meilenstein Grund der Einreichung Initialen des Gutachtersls
  • -102658307 Initial Submission MAA according to Art. 13 TPA, text according to approved EU-SmPC, amendments according to Swissmedic’s template and guidance PharmaContext
  • -102658307 Response to Preliminary Decree Response to Preliminary Decree, Update of MAH, Deletion of pack with 98 capsules Response to Preliminary Decree
  • -102690352 Label update – Desogestrel – Initial submission Label update for interaction with desogestrel and minor corrections Desogestrel
  • -102741102 Type 1AIN variation – Response to Safety Signal Notification. Signal No. 102739454, approved 13 Nov 2024 Revised wording to add postmarketing adverse event for nausea BCRX Type 1AIN
  • -102737333 Type II variation – Study 119 Initial Submission Label update for interaction with ciclosporine. Clarification to Warnings and Precautions requested by EMA. BCRX
  • -
2025 ©ywesee GmbH
Hilfe | FAQ | Anmeldung | Kontakt | Home